NBIX vs YHC · P/E 45, rev $1.77B vs P/E 2.8, rev $1.6M
Neurocrine Biosciences Inc (NBIX) versus LQR House Inc (YHC) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
LQR House Inc (YHC) is a beverages - wineries & distilleries company listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported YHC revenue for 2025-12-31 was $1.6M. Net income was -$25.5M. Revenue was down 37.4% from 2024-12-31 to 2025-12-31. YHC currently screens at market cap $17.8M and trailing P/E 2.8.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. YHC currently screens at market cap $17.8M and trailing P/E 2.8.
Not investment advice. Open the NBIX and YHC stock pages for the full models.
Not investment advice.